Wolchok Solid Tumors 2009 Oncology Response Criteria

Known as: WOLCHOK SOLID TUMORS 2009 
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria. (Wolchok JD, Hoos A, O'Day S, Weber JS… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2017
01220102017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Salim S. Abdool Karim Carl E. Allen Gerard F. Anderson Fabrice Andre Dominick J. Angiolillo George J. Annas Nicholas Anstey… (More)
Is this relevant?
2017
2017
1. Brahmer J, Reckamp KL, Baas P et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J… (More)
Is this relevant?
Review
2016
Review
2016
1. Milano G (2016) Anti-VEGF and anti-EGFR agents open up new horizons changing the landscape for their associations. Cancer… (More)
Is this relevant?
2016
2016
26. Seiwert TY, Fayette J, Cupissol D et al (2014) A randomized, phase II study of afatinib versus cetuximab in metastatic or… (More)
Is this relevant?
2015
2015
1. Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer. N Engl J Med… (More)
Is this relevant?
2013
2013
Anti-PD-1 approaches—important steps forward in metastatic melanoma Several new studies presented at the recent ASCO annual… (More)
Is this relevant?
2013
2013
BIBLIOGRAPHY Culver ME, Gatesman ML, Mancl EE, Lowe DK. Ipilimumab: a novel treatment for metastatic melanoma. Ann Pharmacother… (More)
Is this relevant?
2011
2011
Evaluation of: Wolchok JD, Weber JS, Hamid O et al.: Ipilimumab efficacy and safety in patients with advanced melanoma: a… (More)
Is this relevant?
2010
2010
n engl j med 363;8 nejm.org august 19, 2010 781 Attia P, Phan GQ, Maker AV, et al. Autoimmunity correlates 4. with tumor… (More)
Is this relevant?